Radiation Therapy for Breast Cancer In Situ
Treatment Based on Surgical Approach
- The American Society of Clinical Oncology recommends that radiation therapy is not recommended following total mastectomy with clear margins for DCIS, as this approach is curative 1, 2, 3
- The American College of Radiology recommends that standard radiation therapy is strongly recommended after breast-conserving surgery for DCIS 1, 2, 3
- Adjuvant breast irradiation reduces local recurrence risk by approximately 50-67% across all DCIS subtypes, according to the American Society of Clinical Oncology 1, 2, 3
- Radiation has no demonstrated effect on overall survival, as stated by the American College of Radiology 1, 2
When Radiation MAY Be Omitted After Lumpectomy
- Highly selected low-risk patients may consider omitting radiation, though this remains controversial, according to the American Society of Clinical Oncology 1, 2
- Low-risk criteria include tumor size <10 mm, low or intermediate nuclear grade, adequate surgical margins, and ER-positive status, as defined by the American College of Radiology 1, 2
Standard Radiation Protocol When Used
- The American Society for Radiation Oncology recommends whole-breast radiation: 4,500-5,000 cGy delivered at 180-200 cGy per fraction over 25 treatments 4, 5
- Treatment begins 2-4 weeks post-surgery once adequate healing occurs, as stated by the American College of Radiology 4, 5
- Nodal irradiation is unnecessary for DCIS, according to the American Society for Radiation Oncology 4, 5
Adjuvant Endocrine Therapy
- The American Society of Clinical Oncology recommends that tamoxifen should be considered following breast-conserving surgery (with or without radiation) in ER-positive DCIS 1, 2
- Tamoxifen reduces both invasive and non-invasive breast cancer events by approximately 37%, and decreases risk of contralateral breast cancer, as stated by the American College of Clinical Oncology 1, 2
Common Pitfalls to Avoid
- The American College of Surgeons recommends that axillary lymph node dissection should not be performed for pure DCIS—it is unnecessary, and routine staging tests (bone scan, CT, liver function tests) should not be used in asymptomatic DCIS patients 4
- The American Society of Clinical Oncology recommends that axillary dissection should not be combined with axillary radiation if invasion is found—this dramatically increases lymphedema risk to 40% 3
Radiation Omission After Simple Mastectomy for DCIS
Guideline Recommendations
- The European Society for Medical Oncology (ESMO) Clinical Practice Guidelines state that total mastectomy with clear margins in ductal carcinoma in situ (DCIS) is curative and that adjuvant radiation therapy is not recommended. 6, 7, 8
- For patients with clear surgical margins (≥ 1 mm), no postoperative radiation therapy is indicated. 6, 7, 8
Evidence Strength
- The recommendation to omit routine post‑mastectomy radiation in DCIS with clear margins is supported by Level I evidence and reflects strong consensus among multiple international guideline organizations. 6, 7, 8
Adjuvant Hormonal Therapy
- In estrogen‑receptor‑positive DCIS treated with mastectomy and clear margins, tamoxifen may be offered to lower the risk of contralateral breast cancer (Category 2B). 6